Physician profile
Biagio Manna
NPI 1881628881
$1,637.36
in general payments reported to CMS, 2019-2025
17 companies · $78.32 in 2025
The $78.32 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $206 · 2021: $393 · 2022: $173 · 2023: $195 · 2024: $73.99 · 2025: $78.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $730.50 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $435.42 | 2019-2025 | Grafix Pl, Stravix Pl, Oasis |
| Abbvie INC. | $94.76 | 2023-2024 | |
| Integra Lifesciences Corporation | $89.54 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $59.85 | 2020 | |
| Urgo Medical North America, LLC | $44.84 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Paratek Pharmaceuticals, INC. | $39.34 | 2021 | |
| Kci USA, INC. | $24.58 | 2022 | |
| Convatec INC. | $15.44 | 2021 | |
| Osiris Therapeutics INC. | $15.34 | 2019 | |
| Melinta Therapeutics, LLC | $14.73 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.59 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $13.22 | 2019 | |
| Misonix INC | $12.88 | 2021 | |
| Novo Nordisk INC | $11.38 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11.03 | 2019 | |
| Aroa Biosurgery Incorporated | $9.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Biagio Manna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.